CASE DISCUSSION
Medical management of GI Neuroendocrine tumor
Presented United Arab Emirates by Dr. Cherian ThampyViews
3,708
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
The medical management of gastrointestinal neuroendocrine tumors (NETs) involves a tailored approach based on the tumor's grade, stage, and specific hormonal secretion patterns. Somatostatin analogs, such as octreotide and lanreotide, are commonly used to control symptoms related to hormone...
Case Summary
- Neuroendocrine tumors (NETs) are rare, originating from cells of the diffuse endocrine system, including endocrine glands and cells dispersed throughout the gastrointestinal and respiratory systems. More than half of NET cases arise from the GI tract and respiratory system. These cells receive signals from neurons and secrete hormones into the blood. NETs are a heterogeneous disease with varied extents, tumor burdens, growth rates, grades, and functionality.
Speaker Profile
Dr. Cherian Thampy
Consultant Medical Oncologist, NMC Hospital, Abu Dhabi, United Arab Emirates
Disclosures
Assimilate by Medvarsity requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.